Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Canopy Growth

The most popular marijuana stock has been outperformed by a variety of cannabis growers.

3 Pot Stocks That Have Left Aurora Cannabis Eating Their Dust Since the Beginning of 2018

Aurora Cannabis

Aphria

CannTrust Holdings

HEXO Corp

These are the pot stocks truly expected to "deliver the green."

Ranking Canada's Top 10 Marijuana Growers

This Canadian marijuana company marches to a different drummer.

Is Cronos Group a Buy?

CRON stock has its critics, but in a very speculative cannabis industry there’s good reasons for investors to own Cronos.

The Case for Buying CRON Stock Is Shaping Up

Innovative Industrial Properties

Tilray Brands

Marijuana stocks were down Friday as the Food and Drug Administration began its first public hearing on CBD with a cautionary note.

Marijuana Stocks Fall As FDA Chief Sees 'Real Risks' In CBD Products

If you think dilution is no big deal, then you're flat-out wrong.

Share-Based Dilution Has Crushed Pot Stock Returns

GW Pharmaceuticals

Scotts Miracle-Gro

Several CBD manufacturers, researchers, farmers and retailers have urged the regulatory authority to allow the use of cannabis.

FDA to Hold First Public Hearing on Cannabis: 5 Likely Gainers

MediPharm Labs Corp. is a licensed Canadian producer of cannabis oil under the Access to Cannabis for Medical Purposes Regulations.

MediPharm Labs: Now Working For Cronos And Very Undervalued

These high-growth pot stocks are trading above their respective consensus price targets.

3 Marijuana Stocks Wall Street Thinks Are Overvalued

As legalization gets closer, the trickle of marijuana stocks uplisting to major exchanges could turn into a flood. And you can make a heck of a lot of money investing in the best pot stocks BEFORE they “jump.

Marijuana Stocks: Catch the Next Hot Pot Stock Before It ‘Jumps’

If you play the long game with CRON stock, the underlying company enjoys fundamentals that many of its competitors can only dream about.

The X Factor That Makes Cronos Stock Worth Its Valuation

Cronos Group Inc (NASDAQ: CRON) investors have been on a roller-coaster ride so far in 2019, like other cannabis stocks, Cronos got off to a hot start to the year.

Cronos Group's Stock May Have Finally Found Technical Support

Buying these pot stocks would make Cronos a clear production and extraction services leader in the cannabis space without breaking the bank.

Crazy Idea: Cronos Group Could Buy Both of These Marijuana Stocks

CRON stock continues to rally with all other marijuana stocks, but there's something about Cronos Group that a lot of people just can't shrug off.

Cronos Stock May Be the Least Trusted Name in Cannabis

Wall Street may be vastly underestimating Cronos' long-term value proposition.

Cronos Group Could Be the Bargain of a Lifetime

America's most popular professional sport plans to research the medical buzz surrounding pot.

Hut. Hut. High! The NFL to Consider Marijuana as a Possible Pain Management Tool

Green Thumb Industries Inc.

Which stock wins in a matchup between a leading Canadian marijuana producer and a top U.S. cannabis operator?

Better Marijuana Stock: Cronos Group vs. Green Thumb Industries

Greenlane Holdings

Nasdaq

Village Farms International

Nearly a dozen marijuana stocks are now listed side by side with time-tested businesses on reputable U.S. exchanges.

11 Pot Stocks Now Listed on the NYSE or Nasdaq

Like many other marijuana stocks, CRON stock has been on a downward slide. But this could be an opportunity for investors.

Can Cronos Stock Be a Long-Term Winner?

Zynerba Pharmaceuticals

The CBD trend is heating up as its multiple uses gain traction and laws enable its use. Here are seven marijuana stocks to buy.

7 Marijuana Stocks to Play the CBD Trend

In the ever-volatile marijuana segment, CRON stock simply doesn't stack up well against its peers.

The Bull Thesis for CRON Stock Still Lacks Conviction

These very popular marijuana stocks were scooped up by top-tier money managers.

3 Pot Stocks Wall Street Bought in the First Quarter

Based on its peers' results, Canopy Growth could be in for a pretty good quarter.

Aurora Cannabis, Cronos Group, and Tilray Earnings Results Are In: Here's What They Could Mean for Canopy Growth

Even after a decline, Cronos stock isn't cheap - and management isn't telling a compelling enough story yet.

Without a Better Story, Cronos Stock May Have Further to Fall

Two-faced CRON stock promised much early on, but  a new geopolitical tailwind could change everything for Cronos stock.
The post How Trade War 2.0 Benefits Struggling Cronos Stock appeared first on InvestorPlace.

News for Cronos Group Stock (CRON)